{
  "trial_id": "NCT02411734",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "approached until 100 of them signs the Informed Consent Form",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Admitted for rehabilitation",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "65 years old or older",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "Speaks English",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Speaking English",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "exclusion": [
    {
      "criterion": "Unable to read (even with glasses)",
      "label": "triggers",
      "evidence": "quote"
    },
    {
      "criterion": "Unable to write",
      "label": "triggers",
      "evidence": "quote"
    },
    {
      "criterion": "The expected results of the research: Results of this study will be published in a scientific journal.",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "notes": "Patient has history of acne and mild hirsutism, elevated testosterone levels, gradual enlargement of hands and feet, irregular menstrual cycle, nipple discharge, snoring, headache, facial features of acromegaly and prognathism. Laboratory evaluation reveals IGF-1 of 968 ng/mL and random GH of 19.7 ng/mL.",
  "_meta": {
    "topic_id": "20",
    "trial_id": "NCT02411734",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}